APS 2012: Chronic Pain

news

Fentanyl sublingual spray is generally safe and well tolerated for long-term use in opioid-tolerant patients with cancer for the treatment of breakthrough pain, study investigators at the American Pain Society’s 31st Annual Scientific Meeting reported.

news

Minimal systemic distribution of topical diclofenac sodium gel resulted in a lower incidence of major or moderate drug-drug interactions associated with oral diclofenac and reduced the risk of drug interaction-related adverse events. Study results were reported by Matthew Wieman, MD, from Endo Pharmaceuticals, John H. Peniston, DO, from Novartis Consumer Health, and colleagues at the American Pain Society’s 31st Annual Scientific Meeting.